Current Value
$72.911 Year Return
Current Value
$72.911 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ALHC | 0.02% | $2.95B | +113.16% | 0.00% |
AQB | 0.28% | $2.96M | -61.58% | 0.00% |
ED | -0.52% | $36.75B | +5.26% | 3.28% |
K | -0.54% | $28.49B | +32.17% | 2.77% |
MKTX | 0.55% | $8.01B | -1.42% | 1.39% |
VSTA | -0.58% | $326.82M | +11.64% | 0.00% |
GO | -0.65% | $1.37B | -35.98% | 0.00% |
AIFU | -0.83% | $9.85M | -95.03% | 0.00% |
LTM | 0.97% | $11.01B | -96.75% | 2.75% |
VHC | 1.06% | $34.69M | +74.89% | 0.00% |
WST | 1.14% | $15.14B | -40.50% | 0.39% |
SYPR | 1.15% | $37.69M | +21.48% | 0.00% |
SRRK | 1.24% | $2.92B | +115.29% | 0.00% |
CRVO | 1.44% | $75.19M | -64.53% | 0.00% |
CARV | -1.44% | $7.41M | -22.87% | 0.00% |
AWK | 1.90% | $27.37B | +4.54% | 2.22% |
OPTN | -1.93% | $96.41M | -50.80% | 0.00% |
KR | -2.00% | $44.68B | +24.17% | 1.89% |
CVM | 2.03% | $19.46M | -83.48% | 0.00% |
UUU | 2.20% | $4.93M | +40.20% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FMTO | -13.02% | $45.74M | -99.96% | 0.00% |
VRCA | -9.22% | $59.36M | -92.99% | 0.00% |
VSA | -6.64% | $7.04M | -49.24% | 0.00% |
LITB | -4.36% | $21.28M | -72.45% | 0.00% |
DG | -3.36% | $20.45B | -36.56% | 2.55% |
CBOE | -3.33% | $22.95B | +20.67% | 1.12% |
KR | -2.00% | $44.68B | +24.17% | 1.89% |
OPTN | -1.93% | $96.41M | -50.80% | 0.00% |
CARV | -1.44% | $7.41M | -22.87% | 0.00% |
AIFU | -0.83% | $9.85M | -95.03% | 0.00% |
GO | -0.65% | $1.37B | -35.98% | 0.00% |
VSTA | -0.58% | $326.82M | +11.64% | 0.00% |
K | -0.54% | $28.49B | +32.17% | 2.77% |
ED | -0.52% | $36.75B | +5.26% | 3.28% |
ALHC | 0.02% | $2.95B | +113.16% | 0.00% |
AQB | 0.28% | $2.96M | -61.58% | 0.00% |
MKTX | 0.55% | $8.01B | -1.42% | 1.39% |
LTM | 0.97% | $11.01B | -96.75% | 2.75% |
VHC | 1.06% | $34.69M | +74.89% | 0.00% |
WST | 1.14% | $15.14B | -40.50% | 0.39% |
Double maintains 8 strategies that include GEHC - GE Healthcare Technologies, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -62.11% | $140.49M | 0.59% |
VIXY | -50.56% | $109.64M | 0.85% |
BTAL | -38.37% | $361.41M | 1.43% |
IVOL | -32.07% | $353.94M | 1.02% |
XONE | -25.00% | $603.24M | 0.03% |
SPTS | -19.65% | $5.76B | 0.03% |
TBLL | -19.05% | $2.46B | 0.08% |
XHLF | -18.49% | $1.46B | 0.03% |
FTSD | -17.29% | $212.46M | 0.25% |
BILS | -16.64% | $3.96B | 0.1356% |
GBIL | -15.75% | $6.17B | 0.12% |
UTWO | -15.56% | $387.71M | 0.15% |
FXY | -13.42% | $838.61M | 0.4% |
XBIL | -13.20% | $782.40M | 0.15% |
VGSH | -12.92% | $22.38B | 0.03% |
SCHO | -12.61% | $10.87B | 0.03% |
BIL | -12.57% | $45.95B | 0.1356% |
BILZ | -12.24% | $876.85M | 0.14% |
ULST | -10.97% | $637.77M | 0.2% |
TFLO | -10.23% | $7.06B | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
MOAT | 72.95% | $13.02B | 0.47% |
CGDV | 72.91% | $16.04B | 0.33% |
RSPA | 72.15% | $319.03M | 0.29% |
RSP | 71.99% | $73.05B | 0.2% |
QUS | 71.52% | $1.49B | 0.15% |
IUS | 71.42% | $611.36M | 0.19% |
JEPI | 71.40% | $39.74B | 0.35% |
QDF | 71.39% | $1.80B | 0.37% |
JQUA | 71.37% | $6.06B | 0.12% |
DGRW | 71.36% | $15.01B | 0.28% |
GSEW | 71.32% | $1.21B | 0.09% |
DLN | 71.28% | $4.77B | 0.28% |
TDVG | 71.28% | $819.58M | 0.5% |
TCAF | 71.07% | $4.34B | 0.31% |
VIG | 70.99% | $88.69B | 0.05% |
DSTL | 70.91% | $1.88B | 0.39% |
DGRO | 70.89% | $30.75B | 0.08% |
DUHP | 70.76% | $8.05B | 0.21% |
PMAY | 70.66% | $604.14M | 0.79% |
UJUN | 70.66% | $63.92M | 0.79% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBMN | 0.01% | $446.12M | 0.18% |
STIP | -0.08% | $11.88B | 0.03% |
CGSM | -0.31% | $658.61M | 0.25% |
TDTT | -0.32% | $2.47B | 0.18% |
OWNS | 0.61% | $134.57M | 0.3% |
GSST | -0.64% | $857.21M | 0.16% |
TYA | -0.69% | $149.38M | 0.15% |
IBD | 0.79% | $380.12M | 0.43% |
BUXX | 0.80% | $284.43M | 0.25% |
UDN | 0.93% | $137.74M | 0.78% |
SHY | -1.00% | $24.03B | 0.15% |
BOXX | 1.05% | $6.21B | 0.19% |
IBTM | -1.08% | $313.33M | 0.07% |
BNDX | -1.11% | $64.67B | 0.07% |
IBTF | -1.15% | $2.12B | 0.07% |
SHM | 1.16% | $3.37B | 0.2% |
SHYD | 1.25% | $318.05M | 0.35% |
USFR | -1.25% | $18.91B | 0.15% |
UTEN | 1.26% | $192.72M | 0.15% |
IBTO | 1.44% | $330.69M | 0.07% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DD | 69.87% | $28.53B | -12.11% | 2.28% |
MCO | 66.40% | $87.67B | +18.28% | 0.72% |
FTV | 63.34% | $24.63B | -6.27% | 0.44% |
BN | 62.68% | $98.39B | +33.78% | 0.55% |
TXT | 62.25% | $13.72B | -13.12% | 0.11% |
TEL | 61.81% | $48.37B | +7.96% | 1.60% |
PFG | 61.76% | $18.25B | -3.39% | 3.58% |
BNT | 61.21% | $11.98B | +33.22% | 0.00% |
WAB | 60.99% | $34.95B | +22.55% | 0.42% |
ANSS | 60.76% | $30.20B | +4.88% | 0.00% |
LFUS | 60.56% | $5.35B | -13.23% | 1.28% |
EMR | 60.53% | $67.64B | +6.59% | 1.76% |
SPGI | 60.37% | $159.26B | +18.55% | 0.71% |
CPAY | 60.36% | $24.48B | +22.75% | 0.00% |
PH | 60.10% | $85.95B | +24.68% | 0.99% |
MTD | 59.94% | $23.76B | -25.30% | 0.00% |
NDAQ | 59.84% | $46.66B | +30.61% | 1.18% |
TRU | 59.83% | $17.80B | +15.73% | 0.47% |
RVTY | 59.44% | $10.66B | -16.65% | 0.31% |
PRI | 59.38% | $9.08B | +23.13% | 1.30% |
Yahoo
Key Insights Significantly high institutional ownership implies GE HealthCare Technologies' stock price is sensitive to...
Yahoo
CHICAGO, May 15, 2025--GE HealthCare (Nasdaq: GEHC) today announced the launch of CleaRecon DL, technology powered by a deep-learning algorithm, to improve the quality of cone-beam computed tomography (CBCT) images. This artificial intelligence (AI)-driven solution is designed to remove streak artifacts caused by the pulsatile nature of blood flow in the arteries and changes in the distribution of contrast during CBCT acquisitions in liver, prostate, neuro, and endovascular aortic repair procedu
Finnhub
GE HealthCare Technologies Inc. announced the launch of CleaRecon DL, technology powered by a deep-learning algorithm, to improve the quality of cone-beam computed tomography images. This artificial...
MarketWatch
GE HealthCare Technologies Inc. stock falls Wednesday, underperforms market
Yahoo
GE HealthCare (GEHC) announced the FDA has approved a pediatric indication for its Optison ultrasound enhancing agent. This approval will help improve the clarity of echocardiograms for diagnosing heart conditions in pediatric patients, enhancing the assessment of ventricular function. Optison, the only PEG-free UEA available in the U.S., was first approved for adult use in 1997. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See I
SeekingAlpha
This article provides a top-down analysis of the healthcare sector using value, quality, and momentum metrics. Read the full analysis here on Seeking Alpha, updated for May 2025.